Clinical Trial Update: To Evaluate the Clinical Efficacy of Iguratimod in the Treatment of IgG4 Related Disease (IgG4-RD) With Mild Symptom [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating the efficacy of Iguratimod in mild IgG4-related disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Igg4-related Disease

Drugs mentioned

• Iguratimod (iguratimod)

Snippet

Sponsor: Wen Zhang | Conditions: IgG4-related Disease | Phase 4 | Status: UNKNOWN